Capital Guardian Trust’s Edwards Lifesciences EW Stock Holding History

Capital Guardian Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$33M	Buy	+535,149	New	+$32.4M	0.44%	90

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Guardian Trust's EW Position: Q2 2019 in Review

Capital Guardian Trust opened a new position in Edwards Lifesciences (EW) in Q2 2019: 535,149 shares worth $33M. The stake represents 0.44% of the portfolio and ranks #90 among its holdings.

921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

Capital Guardian Trust held 535,149 shares of Edwards Lifesciences worth $33M as of Q2 2019.
Edwards Lifesciences was a new Capital Guardian Trust position in Q2 2019.
Edwards Lifesciences made up 0.44% of Capital Guardian Trust's portfolio in Q2 2019, its #90 holding.
921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.